Altered structure and expression of RB1 gene and increased phosphorylation of pRb in human vestibular schwannomas

Molecular and Cellular Biochemistry

Volumn 271, Issue 1-2, 2005, Pages 113-121

  Thomas, R ^a   Prabhu, P D Antony Herold ^a   Mathivanan, J ^a   Rohini, ^a   Sivakumar, D ^a   Jayakumar, P N ^a   Devi, B Indira ^a   Satish, S ^a   Sastry, K V R ^a   Gope, R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Gene expression; Gene structure; Human retinoblastoma gene (RB1); Human vestibular schwannomas; pRb; pRb phosphorylation; Tumor suppressor gene

Indexed keywords

APOPTOSIS INHIBITOR; DNA; GENE PRODUCT; MESSENGER RNA; PROTEIN PRB; UNCLASSIFIED DRUG; RETINOBLASTOMA PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE STRUCTURE; GENETIC ANALYSIS; GENOMIC INSTABILITY; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEURILEMOMA; NORTHERN BLOTTING; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; NEUROFIBROMATOSIS; NEUROMA; PATHOLOGY; PHOSPHORYLATION; REFERENCE VALUE;

ADOLESCENT; ADULT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 2; NEUROMA, ACOUSTIC; PHOSPHORYLATION; REFERENCE VALUES; RETINOBLASTOMA PROTEIN;

EID: 20244368347     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-5617-0     Document Type: Article

References (38)

1. Martuza RL, Eldridge R: Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med 318: 684-688, 1988
2. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldrige R, Aurias A, Delattre O, Thomas G: Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363: 515-521, 1993
3. Jacoby LB, Jones D, Davis K, Kronn D, Short MP, Gusella J, MacCollin M: Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet 61: 1293-1302, 1997
4. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996 10.1126/ science.274.5293.1672
5. Jacks T, Weinberg RA: The expanding role of cell cycle regulators. Science 280: 1035-1036, 1998
6. Hanahan D, Weinberg RA: Hallmarks of cancer. Cell 100: 57-70, 2000 10.1016/S0092-8674(00)81683-9
7. Gope R, Christensen MA, Thorson A, Lynch HT, Smyrk T, Hodgson C, Wildrick DM, Gope ML, Boman BM: Increased expression of the retinoblastoma gene in human colorectal carcinomas relative to normal colonic mucosa. J Natl Cancer Inst 82: 310-314, 1990
8. Gope ML, Chun M, Gope R: Comparative study of the expression of Rb and p53 genes in human colorectal cancers, colon carcinoma cell lines and synchronized human fibroblasts. Mol Cell Biochem 107: 55-63, 1991
9. Gope R, Gope ML: Abundance and state of phosphorylation of the retinoblastoma susceptibility gene product in human colon cancer. Mol Cell Biochem 110: 123-133, 1992
10. Yamamoto H, Soh J-W, Monden T, Klein MG, Zhang LM, Shirin H, Arber N, Tomita N, Schieren I, Stein CA, Weinstein IB: Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis. Clin Cancer Res 5: 1805-1815, 1999
11. Chatterjee SJ, George B, Goebell PJ, Alavi-Tafreshi M, Shi SR, Fung YK, Jones PA, Cordon-Cardo C, Datar RH, Cote RJ: Hyperphosphorylation of pRb: A mechanism for RB tumor suppressor pathway inactivation in bladder cancer. J Pathol 203: 762-770, 2004
12. Botos J, Smith III R, Kochevar DT: Retinoblastoma function is a better indicator of cellular phenotype in cultured breast adenocarcinoma cells than retinoblastoma expression. Exp Biol Med (Maywood) 227: 354-362, 2002
13. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA: Effects of an Rb mutation in the mouse. Nature 359: 295-300, 1992
14. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A: Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288-294, 1992
15. Dyson N: The regulation of E2F by pRB-family proteins. Genes Dev12: 2245-2262, 1998 1:CAS:528:DyaK1cXltlagu74%3D
16. Taya Y, Yasuda H, Kamijo M, Nakaya K, Nakamura Y, Ohba Y, Nishimura S: In vitro phosphorylation of the tumor suppressor gene-RB protein by mitosis-specific histone-H1 kinase. Biochem Biophys Res Commun 164: 580--586, 1989
17. Lasak JM, Welling DB, Akhmametyeva EM, Salloum M, Chang LS: Retinoblastoma-cyclin-dependant kinase pathway deregulation in vestibular schwannomas. Laryngoscope 112: 1555-1561, 2002
18. Bookstein R, Lee EY-HP, To H, Young L-J, Sery TW, Hayes RC, Friedman T, Lee W-H: Human retinoblastoma susceptibility gene: Genomic organization and analysis of heterozygous intragenic deletion mutants. Proc Natl Acad Sci. USA 85: 2210-2214, 1988
19. Toguchida J, McGee TL, Paterson JC, Eagle JR, Tucker S, Yandell DW, Dryja TP: Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics 17: 535-543, 1993
20. Gouyer V, Gazzeri S, Brambilla E, Bolon I, Moro D, Perron P, Benabid AL, Brambilla C: Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuroendocrine lung carcinomas. Int J Cancer 58: 811-824, 1994
21. Xu HJ, Cairns P, Hu SX, Knowles MA, Benedict WF: Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. Int J Cancer 53: 781-784, 1993 1:STN:280:ByyC1MvjvFY%3D
22. Ma D, Zhou P, Harbour JW: Distinct mechanisms for regulating the tumor suppressor and antiapoptotic functions of Rb. J Biol Chem278: 19358-19366, 2003
23. ME Cohen 1995 Primary and secondary tumors of the central nervous system In: W.G. Bradley R.B. Daroff G.M. Fenichel and C.D. Marsden (eds) Neurology in Clinical Practice Butterworth-Heinemann Boston, USA 1089-1108 vol. II
24. Mawrin C, Kirches E, Boltze C, Dietzmann K, Roessner A, Schneider-Stock R: Immunohistochemical and molecular analysis of p53, RB, and PTEN in malignant peripheral nerve sheath tumors. Virchows Arch 440: 610-615, 2002
25. Loeb LA: A mutator phenotype in cancer. Cancer Res 61: 3230-3239, 2001
26. Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih IeM, Vogelstein B, Lengauer C: The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci, USA 99: 16226-16231, 2002
27. INK4 protein in gallbladder carcinomas. Clin Cancer Res 6: 4096-4100, 2000
28. Borg A, Zhang OX, Alm P, Olsson H, Sellberg G: The retinoblastoma gene in breast cancer: Allele loss is not correlated with loss of gene protein expression. Cancer Res 52: 2991-2994, 1992
29. Walther MM, Gnarra JR, Elwood L, Xu HJ, Florence C, Anglard P, Hu SX, King C, Trahan E, Hurley K: Loss of heterozygosity occurs centromeric to RB without associated abnormalities in the retinoblastoma gene in tumors from patients with metastatic renal cell carcinoma. J Urol 153: 2050-2054, 1995
30. Cooney KA, Wetzel JC, Merajver SD, Macoska JA, Singleton TP, Wojno KJ:. Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res 56: 1142-1145, 1996
31. Bates AS, Farrell WE, Bicknell EJ, McNicol AM, Talbot AJ, Broome JC, Perrett CW, Thakker RV, Clayton RN. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J Clin Endocrinol Metab82: 818-824, 1997 10.1210/ jc.82.3.818
32. Simpson DJ, Frost SJ, Bicknell JE, Broome JC, McNicol AM, Clayton RN, Farrell WE: Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas. Carcinogenesis 22: 1149-1154, 2001
33. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY: Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Science 235: 1394-1399, 1987
34. Fitch ME, Cross IV, Turner SJ, Adimoolam S, Lin CX, Williams KG, Ford JM: The DDB2 nucleotide excision repair gene product p48 enhances global genomic repair in p53 deficient human fibroblasts. DNA repair 2: 819-826, 2003
35. Haas-Kogan DA, Kogan SC, Levi D, Dazin P, T'Ang A, Fung YK, Israel MA: Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 14: 461-472, 1995
36. Zacksenhaus E, Jiang Z, Chung D, Marth JD, Phillips RA, Gallie BL: PRb controls proliferation differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev10: 3051-3064, 1996
37. Classon M, Harlow E: The retinoblastoma tumor suppressor in development and cancer. Nat Rev Cancer 2: 910-917, 2002
38. Gope R, Gope ML: Effect of sodium butyrate on the expression of retinoblastoma (RB1) and p53 gene and phosphorylation of retinoblastoma protein in human tumor cell line HT29. Cell Mol Biol 39: 589-597, 1993